<qa>  What is the name of the monoclonal antibody anti-anb3 integrinPatients receive monoclonal antibody anti-anb3 integrin IV over 30 minutes weekly. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity. 